This compound is a protected intermediate for modified nucleosides, featuring a silyl-protected ribose moiety and a trityl-type protecting group. It is used in the synthesis of nucleoside analogs for pharmaceutical research and manufacturing.
نطاق المحتوى: تتعلق المعلومات الواردة في هذه الصفحة بتحديد المواد الكيميائية وبسياقات التوريد الصناعي والبحث والإنتاج. وهي لا تشكّل ادعاءً علاجياً أو نصيحة طبية أو إرشادات لاستخدام الأدوية.
هل تشتري أو تورد هذا المركب؟
أضف مخزونك أو أنشر طلب شراء
CAS 875302-41-3
5'-O-(4,4'-dimethoxitrityl)-3'-O-(tert-butyldimethylsilyl)-1-methylpseudouridine
Pharmaceutical intermediate for modified nucleoside synthesis
5'-O-(4,4'-dimethoxitrityl)-1-N-methylpseudouridine
Pharmaceutical intermediate for RNA synthesis
5'-O-DMT-2'-O-TBDMS-Pseudouridine
Pharmaceutical intermediate for nucleoside synthesis
5'-DMT-3'-O-TBDMS-N1-Me-Pseudouridine-CE-Phosphoramidite
Phosphoramidite building block for RNA synthesis
[3-[4-(4-aminobenzoyl)oxyphenyl]-2-(octadec-9-enoylamino)propyl] phosphate;[3-(4-iodophenyl)-2-(octadec-9-enoylamino)propyl] phosphate;[3-[4-[(3-methoxyphenyl)methoxy]phenyl]-2-(octadec-9-enoylamino)propyl] phosphate;bis([2-(octadec-9-enoylamino)-3-[4-[(4-pentylphenyl)methoxy]phenyl]propyl] phosphate);[2-(octadec-9-enoylamino)-3-(4-phenylphenyl)propyl] phosphate;[2-(octadec-9-enoylamino)-3-(4-prop-2-enoxyphenyl)propyl] phosphate
raw material for therapeutic antibody
(4S,5R)-5-(3,5-bis(trifluoromethyl)phenyl)-4-methyloxazolidin-2-one
Pharmaceutical intermediate for fine chemicals
(4-Fluoro-5-isopropyl-2-methoxyphenyl)boronic acid
Pharmaceutical intermediate
5'-DMT-3'-O-TBDMS-PseudoUridine
pharmaceutical intermediate for modified nucleosides
5-[(2S,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-3-[tert-butyl(dimethyl)silyl]oxy-4-hydroxyoxolan-2-yl]-1-methylpyrimidine-2,4-dione
LAUAFECHUGXCAW-NXVJRICRSA-N
CC(C)(C)[Si](C)(C)O[C@@H]1[C@@H]([C@H](O[C@H]1C2=CN(C(=O)NC2=O)C)COC(C3=CC=CC=C3)(C4=CC=C(C=C4)OC)C5=CC=C(C=C5)OC)O
—